GoScript(TM) Reverse Transcriptase, 500 rxn and 1 more item

University of Virginia awarded contract A207_PO-0468449 to Promega Corporation on August 13, 2026, with a cumulative contract value of $899. While specific product and service descriptions are not detailed in the available documentation, Promega Corporation's primary business operations indicate the contract likely involves the provision of life sciences research products, molecular biology reagents, or related laboratory supplies commonly procured by academic research institutions.

The contract represents a purchase order engagement with University of Virginia serving as the contracting organization in Virginia. The modest contract value of $899 suggests this award represents either a single purchase order or a limited-scope supply arrangement rather than a comprehensive service delivery engagement. Without additional documentation specifying the statement of work, period of performance, or specific place of performance beyond the University of Virginia's location, further details regarding the scope, duration, or geographic delivery parameters cannot be reasonably inferred from the materials provided.